COMMUNIQUÉS West-GlobeNewswire

Wright Medical Group N.V. Reports 2018 First Quarter Financial Results
09/05/2018
First Quarter 2018 Net Sales of $199 Million First Quarter 2018 Net Loss From Continuing Operations of $20 Million; Non-GAAP Adjusted EBITDA From Continuing Operations of $27 Million U.S. Upper Extremities Business [...]
Adamas Announces New Employment Inducement Grant
09/05/2018
EMERYVILLE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that the compensation committee of the company’s board of directors granted four new employees the option [...]
Fluidigm to Participate in Upcoming Investor Events
09/05/2018
SOUTH SAN FRANCISCO, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ), an innovative life science company that develops, manufactures and markets multiparameter mass cytometry technology and [...]
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2018
09/05/2018
Reports Net Revenues of $58.4 Million for the Three Months Ended March 31, 2018 RANCHO CUCAMONGA, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) (“Amphastar” or the “Company”) [...]
Novavax Reports First Quarter 2018 Financial Results
09/05/2018
GAITHERSBURG, Md., May 09, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX ) today announced its financial results for the first quarter ended March 31, 2018. First Quarter and Subsequent Achievements: RSV F [...]
ChemoCentryx Reports First Quarter 2018 Financial Results and Recent Highlights
09/05/2018
-- Patient enrollment in Phase III ADVOCATE trial of avacopan in the treatment of ANCA-associated vasculitis exceeds 85%; Conditional Marketing Authorization (CMA) application under review with European Medicines Agency [...]
Portola Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
09/05/2018
-- Conference Call Today at 4:30 p.m. ET -- SOUTH SAN FRANCISCO, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today reported financial results for the three months ended March [...]
Aileron Therapeutics Reports First Quarter 2018 Financial Results
09/05/2018
CAMBRIDGE, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN ), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases, today reported business [...]
Accelerate Diagnostics reports Q1 2018 financial results
09/05/2018
TUCSON, Ariz., May 09, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced financial results for the quarter ending March 31, 2018. The company generated revenue of $801,000, up 51% from the prior year [...]
Savara Reports First Quarter 2018 Financial Results and Provides Business Update
09/05/2018
Molgradex Phase 3 IMPALA study enrollment on track for completion in Q3 2018 AeroVanc Phase 3 AVAIL study enrollment on track for completion in Q1 2019 Molgradex Phase 2a OPTIMA study enrollment on track for completion [...]
FibroGen Reports First Quarter 2018 Financial Results
09/05/2018
Pamrevlumab Data to be Presented at ATS 2018 and ASCO 2018 Roxadustat U.S. Phase 3 Clinical Studies on Track to Readout in Fourth Quarter 2018 Conference Call Today at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time SAN [...]
Collegium Reports First Quarter Financial Results and Provides Corporate Update
09/05/2018
Net revenue of $63.7 million, compared to $10.8 million in Q4 2017 Xtampza ER prescriptions grew by 72% in the first quarter Integration of the Nucynta franchise into the commercial organization Conference call [...]
Sientra Reports First Quarter 2018 Financial Results
09/05/2018
Achieves Highest Net Sales in Company’s History Received FDA Approval of PMA Supplement Launched OPUS™ Branded Breast Products and miraDry fresh™ Enhanced Protocol Completed Upsized Follow-on Public Offering of Common [...]
Rhythm Pharmaceuticals Announces Nature Medicine Publication of Longer-Term Data from Phase 2 Study of Setmelanotide for Treatment of LEPR Deficiency Obesity
09/05/2018
Longer-term data from open label study show reductions in hyperphagia and body weight In vitro analyses advance understanding of setmelanotide’s activity at the MC4 receptor, a part of a key pathway regulating energy [...]
Zogenix Provides Corporate Update and Reports First Quarter Financial Results
09/05/2018
Following receipt of Breakthrough Therapy Designation, conducted successful Type B meeting with FDA confirming adequacy of Phase 3 program for ZX008 NDA in Dravet syndrome Study 1504 fully enrolled with 87 randomized [...]
Rhythm Pharmaceuticals to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
09/05/2018
BOSTON, May 09, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM ), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity [...]
Cara Therapeutics Reports First Quarter 2018 Financial Results
09/05/2018
Conference call today at 4:30 p.m. ET STAMFORD, Conn., May 09, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA ), a biopharmaceutical company focused on developing and commercializing new chemical [...]
MannKind Corporation Reports 2018 First Quarter Financial Results
09/05/2018
Conference Call to Begin Today at 5:00 PM ET Q1 2018 Afrezza Net Revenue was $3.4 million; +184% vs. Q1 2017 (+234% under the 2017 revenue recognition model) Q1 2018 Net Cash Used in Operating Activities was $21.7 [...]
Immunomedics Announces Third Quarter Fiscal 2018 Results and Provides Corporate Update
09/05/2018
Biologics License Application (BLA) Remains on Track to be Submitted by the End of May 2018 Leadership Team Expanded with Appointment of Dr. Robert Iannone, Head of Research & Development and Chief Medical Officer [...]

Pages